この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2002/4/151 分で読めます
Implantation or Injectable Dosage Form New Animal Drugs; Sometribove Zinc Suspension
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Monsanto Co. which provides for subcutaneous injection of sometribove zinc suspension in healthy lactating dairy cows to increase the production of marketable milk with no restriction on injection site. Three injection sites are recommended.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →